Non-Hodgkin's Lymphoma News

Combining stem cell transplants with cutting-edge immunotherapy prevents leukemia relapses in young people and improves their chances of survival, new research suggests.

A blood test that checks the level of tumor cells before and after cancer treatment could tell doctors within days or weeks, rather than months, whether the treatment has been effective, researchers report.

The FDA has approved a first-of-its-kind treatment, called CAR T-cell therapy, to treat a type of leukemia in children and young adults.

Expensive but potent leukemia therapy genetically transforms patients' immune system cells to fight disease

Dasatinib prolonged survival in chronic myeloid leukemia patients, study says

Plus, there's no evidence of safety concerns linked to long-term use of the drug, researchers say

Over one-third of patients appeared disease-free 6 months after single treatment, report says

Tweaking T-cells from healthy donor allowed infants to reach remission, researchers report

Made by combining immune cells, cancer cells, it's kept some study patients in remission for nearly 5 years

Early trial results termed 'fantastic step forward' in fight against non-Hodgkin lymphoma

Donors and recipients don't need to be a perfect match, researcher says

Organ damage improved in 60 percent of patients with advanced systemic mastocytosis

Test finds those who might respond well, may spare others treatment side effects

Outcomes after the therapy similar to those for patients who don't carry the virus

Over 5 years, researchers estimate more than $9 million in insurance savings

Study showed many were able to avoid graft-versus-host disease

First Generic Version of Gleevec Approved by FDA

Doctors in the United Kingdom have successfully treated a baby girl with incurable leukemia by using a gene-editing technique that had been tested only in the laboratory. WebMD shares the details.

Combining glitazones with standard treatment improved survival in small study

Researchers find gene variant associated with acute lymphoblastic leukemia

Study suggests chemotherapy, radiation can damage the heart for decades to come

In study, brentuximab extended time patients survived without further progression of the blood cancer

Nivolumab harnesses power of immune system to attack cancer in patients who've failed other therapy

Cancer patients are finding new hope -- and even remission -- in an experimental treatment called immunotherapy.

But, some advanced acute lymphoblastic leukemia patients relapsed, study finds